|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-2-11
|
|
pubmed:abstractText |
Arsonolipid-containing liposomes have been recently prepared. The demonstrated antileukemic action of arsenic trioxide prompted us to study their effect on the viability of several types of cancer cells to investigate the possibility of relevant applications. Five different cell types, three malignant (HL-60, C6. and GH3) and two non-malignant (HUVEC and RAME), were used.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0724-8741
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
79-86
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11837704-Animals,
pubmed-meshheading:11837704-Arsenicals,
pubmed-meshheading:11837704-Cell Line,
pubmed-meshheading:11837704-Cell Survival,
pubmed-meshheading:11837704-Humans,
pubmed-meshheading:11837704-Inhibitory Concentration 50,
pubmed-meshheading:11837704-Lipids,
pubmed-meshheading:11837704-Liposomes,
pubmed-meshheading:11837704-Oxides,
pubmed-meshheading:11837704-Palmitic Acid,
pubmed-meshheading:11837704-Tumor Cells, Cultured
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Arsonoliposomes, a novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture.
|
|
pubmed:affiliation |
Laboratory of Pharmaceutical Technology, University of Patras, Greece.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
